Sick Sinus Syndrome
Sinus node dysfunction causing inappropriate bradycardia, sinus pauses, or alternating tachy-brady patterns — leading indication for permanent pacing.
Also known as: sick sinus syndrome, SSS, sinus node dysfunction, tachy-brady syndrome, SND
Overview
Heterogeneous syndrome of sinus node dysfunction producing symptomatic inappropriate sinus bradycardia, sinus pauses or arrest, chronotropic incompetence (failure to increase heart rate appropriately with exertion), sinoatrial exit block, or alternating periods of bradycardia and supraventricular tachyarrhythmias (most often atrial fibrillation) — the latter pattern is termed 'tachy-brady syndrome.'
Epidemiology
Most common indication for permanent pacemaker implantation in the United States. Incidence rises sharply with age; primarily a disease of older adults (median age at diagnosis ~70). Approximately 1 case per 600 cardiac patients age >65. Lifetime risk of new AFib in patients with SSS is high.
Keep reading — start your free trial
You've read your 2 free diagnosis previews. Create your free account to unlock the full Sick Sinus Syndrome outline — plus all 514 diagnoses, 3,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Risk factors
- Advanced age (idiopathic age-related fibrosis of the sinus node and surrounding atrial tissue)
- Underlying structural heart disease: ischemic heart disease, prior MI, hypertensive heart disease, cardiomyopathies
- Infiltrative diseases: amyloidosis, sarcoidosis, hemochromatosis
- Cardiac surgery (especially involving the atrium or sinus node region)
- Medications: beta-blockers, nondihydropyridine CCBs (diltiazem, verapamil), digoxin, amiodarone, ivabradine, lithium, donepezil
- Inferior MI involving the sinus node artery (right coronary in ~60%, left circumflex in ~40%)
- Familial / genetic (SCN5A, HCN4 mutations)
Pathophysiology
Progressive degeneration and fibrosis of the sinus node and surrounding atrial myocardium impair automaticity and conduction from the SA node to the surrounding atrium. The result is inappropriate bradycardia and pauses. Atrial fibrosis simultaneously creates substrate for atrial arrhythmias, producing the tachy-brady pattern. After termination of tachyarrhythmias, prolonged sinus pauses (offset pauses) may produce symptoms.
Clinical presentation
Symptoms
- Fatigue, lightheadedness, presyncope, syncope
- Exertional dyspnea and exercise intolerance (chronotropic incompetence)
- Palpitations from intermittent tachyarrhythmias (often AFib)
- Cognitive slowing, confusion
- Sometimes asymptomatic with incidental bradycardia or pauses on ECG
Signs / physical exam
- Bradycardia or irregular pulse
- May appear well between episodes
- Findings of underlying heart disease if present
Classic findings
Older adult with intermittent syncope, exercise intolerance, and ambulatory ECG capturing alternating bradycardia, pauses, and atrial tachyarrhythmias — the tachy-brady pattern.
Differential diagnosis
- Athletic heart / physiologic bradycardia — Resting HR may be 40s-50s in well-trained athletes but with appropriate chronotropic response to exertion; asymptomatic
- Medication-induced bradycardia — Beta-blocker, diltiazem, verapamil, digoxin, amiodarone use; resolves on holding offending agent
- Hypothyroidism — Other systemic features, elevated TSH
- Obstructive sleep apnea — Nocturnal bradycardia with daytime sleepiness; polysomnography
- AV block (especially second/third-degree) — PR prolongation/dissociation rather than slow sinus rate; pacing indication is similar in symptomatic forms
- Vasovagal syncope / neurally mediated — Situational triggers, prodrome of warmth/nausea, normal Holter outside of episode
- Carotid sinus hypersensitivity — Provoked by neck pressure or head turning; >3 sec asystole with carotid massage
Diagnostic workup
Diagnostic criteria
Diagnosis requires correlation of bradyarrhythmia or pauses with symptoms. Common ECG findings supporting SSS: persistent sinus bradycardia <50 bpm without identifiable reversible cause, sinus pauses ≥3 seconds, chronotropic incompetence on exercise testing, alternating bradycardia and atrial tachyarrhythmias.
Labs
- BMP including potassium, magnesium, calcium
- TSH
- Digoxin or other relevant drug levels
- Troponin if ACS suspected (especially with inferior wall ischemia)
Imaging
- 12-lead ECG: inappropriate sinus bradycardia (rate <50 awake without identifiable cause), sinus pauses, sinoatrial exit block, ectopic atrial rhythm, junctional escape, atrial arrhythmias
- Ambulatory monitoring — KEY diagnostic tool: 24-48 hour Holter, 30-day event monitor, 14-30 day patch monitor, or implantable loop recorder if symptoms are infrequent
- Exercise stress testing for chronotropic incompetence (failure to achieve >80% of age-predicted max HR or HR <100 bpm during peak exercise)
- Echocardiography to evaluate for structural heart disease
- Electrophysiology study selectively used if diagnosis remains unclear
Diagnostic algorithm
| ECG Pattern | Description | Implication |
|---|---|---|
| Inappropriate sinus bradycardia | Persistent HR <50 awake without reversible cause | Suggestive of SND |
| Sinus pause / arrest | Pause ≥3 seconds with absent P wave | Symptomatic pauses warrant pacing |
| Sinoatrial exit block | Multiple of P-P interval skipped | SND variant |
| Chronotropic incompetence | <80% predicted max HR on exercise | Pacing for symptomatic exercise intolerance |
| Tachy-brady pattern | AFib alternating with bradycardia or pauses | Pacemaker permits safe AV nodal blocker use |
| Junctional escape rhythm | Narrow QRS at 40-60 without preceding P | Compensatory rhythm in failed sinus node |
Treatment
First-line
- Discontinue offending medications if present (beta-blockers, CCBs, digoxin, amiodarone, ivabradine) and reassess
- Correct underlying conditions: hypothyroidism, electrolyte abnormalities, OSA
- Permanent pacemaker is the definitive therapy for symptomatic sick sinus syndrome — most often dual-chamber (DDD) pacing with mode-switching capability; single-chamber atrial pacing (AAI) is rarely used now given the risk of subsequent AV block. Class I indication: symptomatic SND with documented symptomatic bradycardia or pauses, or chronotropic incompetence
- Asymptomatic sick sinus syndrome does NOT require pacing
Second-line / adjunct
- Manage atrial tachyarrhythmias in tachy-brady syndrome: rate control becomes much safer after pacemaker placement, allowing use of beta-blockers, CCBs, or antiarrhythmic drugs that would otherwise exacerbate bradycardia
- Anticoagulation for AFib per CHA2DS2-VASc score (direct oral anticoagulants for non-valvular AFib)
- Catheter ablation of atrial fibrillation can sometimes improve sinus node function and reduce dependence on pacing
- Theophylline or oral atropine analogs are rarely used as bridges in select cases
Complications
- Syncope with injury
- Atrial fibrillation and thromboembolic stroke
- Heart failure from chronotropic incompetence and chronic AFib
- Pacemaker complications (infection, lead displacement, pacemaker-mediated tachycardia)
- Progressive conduction system disease (development of AV block over time)
PANCE pearls
- Sick sinus syndrome is the most common indication for permanent pacemaker placement in the U.S.
- Symptom-rhythm correlation is essential — bradycardia or pauses must be linked to symptoms before committing to pacemaker therapy. Ambulatory monitoring is the workhorse.
- Beta-blockers, nondihydropyridine CCBs, digoxin, amiodarone, and ivabradine are common culprits — always review the medication list before diagnosing SSS.
- Tachy-brady syndrome: pacemaker controls bradycardia and enables safe use of AV nodal blockers and antiarrhythmics for the tachy component.
- Anticoagulation is required for AFib in SSS regardless of pacemaker placement — CHA2DS2-VASc guides therapy.
Images
References
- ACC/AHA/HRS 2018 — 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients with Bradycardia and Cardiac Conduction Delay (Kusumoto et al., JACC 2019)
- ESC 2021 — 2021 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy (Glikson et al., Eur Heart J 2021)
- MOST Trial — Mode Selection Trial in Sinus-Node Dysfunction (Lamas et al., NEJM 2002)
Practice Cardiovascular questions on FirstPassPA
Turn this outline into retention. 3,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Start studying free → Browse all 514 diagnosesEducational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants.